Business Context and Reporting Period
This Form 8-K filing by Veracyte, Inc. (Delaware) was submitted on February 25, 2014, reporting events that occurred on February 19, 2014. The filing addresses Item 5.02 regarding the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation adjustments.
Material Changes and Compensation Details
The Board of Directors approved the following compensation changes for Named Executive Officers (NEOs) effective February 19, 2014:
- 2013 Executive Bonus Awards: Cash bonuses were approved based on 2013 corporate and individual performance:
- Bonnie H. Anderson (CEO): $170,000
- Shelly D. Guyer (CFO): $69,000
- Christopher M. Hall (CCO): $80,000
- 2014 Base Salary Increases:
- Bonnie H. Anderson (CEO): $425,000
- Shelly D. Guyer (CFO): $300,000
- Christopher M. Hall (CCO): $329,314
- 2014 Executive Bonus Plan Targets: Targets set as a percentage of 2014 base salary:
- Bonnie H. Anderson (CEO): 50%
- Shelly D. Guyer (CFO): 30%
- Christopher M. Hall (CCO): 30%
- 2014 Equity Awards: Stock option grants approved:
- Bonnie H. Anderson (CEO): 140,000 shares
- Shelly D. Guyer (CFO): 70,000 shares
- Christopher M. Hall (CCO): 70,000 shares
Guidance, Outlook, and Risks
Corporate goals for the 2014 Executive Bonus Plan are expected to be approved by the end of March 2014. Actual bonus awards may exceed or fall short of targets based on the Board's discretion regarding corporate and individual performance. Bonuses may be paid in cash, fully vested stock options, restricted stock, or a combination thereof. The filing does not disclose specific operational risks or contingencies beyond the discretionary nature of the bonus plan.
Investor Verification Checklist
- Verify the specific corporate goals for 2014 once approved by the Board (expected by end of March 2014).
- Review the terms of the 2014 stock option grants, including exercise price and vesting schedules, which are not detailed in this summary.
- Confirm the total number of shares authorized under the Company's equity incentive plans to assess dilution impact.
- Monitor future filings for the actual payout of 2014 bonuses, as they are contingent on performance.